"... here is what we have to show for our vaccine efforts: a few Phase 3 clinical trials, one of which actually made the disease worse, and another with a success rate of just 30 percent. Researchers say they don’t expect a successful H.I.V. vaccine until 2030 or later, putting the timeline at around 50 years. That’s unlikely to be the case for Covid-19, because, as opposed to H.I.V., it doesn’t appear to mutate significantly and exists within a family of familiar respiratory viruses. Even still, any delay will be difficult to bear. But the history of H.I.V. offers a glimmer of hope for how life could continue even without a vaccine. Researchers developed a litany of antiviral drugs that lowered the death rate and improved health outcomes for people living with AIDS. Today’s drugs can lower the viral load in an H.I.V.-positive person so the virus can’t be transmitted through sex. Therapeutic drugs, rather than vaccines, might likewise change the fight against Covid-19.... Combine that with rigorous testing and contact tracing — where infected patients are identified and their recent contacts notified and quarantined — and the future starts looking a little brighter.... If all those things come together, life might return to normal long before a vaccine is ready to shoot into your arm."
From "How Long Will a Vaccine Really Take?" (NYT). The article examines many things that could be done to speed up the development and distribution of a vaccine (with the best possible result arriving in the middle to end of next year).
Subscribe to:
Post Comments (Atom)
Cat Moonblack gold PU
Cat Moonblack gold PU adalah salah satu series yang mengandung partikel kecil seperti crystal yang dan memiliki effect lebih gelap sehing...

-
I have been reading an interesting book “The Mirror of the Gods” by Malcolm Bull. The author discusses the revival of Greco-Roman mythology...
-
... Jimmy Fallon takes on the even more challenging role of playing Nicolas Cage playing Tiger King:
-
This summary is not available. Please click here to view the post.
No comments:
Post a Comment